Humboldt Fund is an exclusive synthetic biology venture capital firm that invests in early-stage companies (Pre-Seed, Seed, Series A) focused on replacing industrial inputs with biology-based alternatives. Their strategy centers on applying revolutionary biotechnology to transform sectors such as chemicals, materials, food, and medicine, operating at the intersection of engineering, physical, and life sciences.
Portfolio
4
Fund Size
—
Top Stage
Seed
Last 12 Mo
0
Stage Distribution
Portfolio
4 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Compound Foods | Seed | $4.5M | Aug 2021 |
| Meatable | Series B | $47M | Mar 2021 |
| Cellino | Seed | $16M | — |
| Finless Foods | Series B | $34M | — |
Top Co-Investors
Lowercarbon Capital1 shared
Collaborative Fund1 shared
Maple VC1 shared
GV (Google Ventures)1 shared
Section 321 shared
BlueYard Capital1 shared
Agronomics1 shared
The Engine1 shared
Khosla Ventures1 shared
8VC1 shared
Hanwha Solutions1 shared
Olive Tree Ventures1 shared
Gaingels1 shared
Draper Associates1 shared
Sustainable Ocean Alliance1 shared
SOSV1 shared
Last updated: 3 March 2026